Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed A Abdelgalil

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Profiles of Drug Substances, Excipients, and Related Methodology|April 15, 2023
Crizotinib: A comprehensive profileAhmed A Abdelgalil, Hamad M Alkahtani
Profiles of Drug Substances, Excipients, and Related Methodology|April 15, 2023
Lapatinib: A comprehensive profileAhmed A Abdelgalil, Hamad M Alkahtani
Profiles of Drug Substances, Excipients, and Related Methodology|February 29, 2024
Regorafenib: A comprehensive drug profileAhmed A Abdelgalil, Hamad M Alkahtani
Profiles of Drug Substances, Excipients, and Related Methodology|April 29, 2019
SorafenibAhmed A Abdelgalil, Hamad M Alkahtani, Fahad I Al-Jenoobi
Profiles of Drug Substances, Excipients, and Related Methodology|March 14, 2020
ErlotinibAhmed A Abdelgalil, Hamad M Al-Kahtani, Fahad I Al-Jenoobi
Saudi Journal of Biological Sciences|April 30, 2020
Cigarette waste: Assessment of hazard to the environment and health in Riyadh cityWajhul Qamar, Ahmed A Abdelgalil, Suliman Aljarboa, et al.
European Journal of Pharmacology|June 8, 2020
The protective effect of losartan against sorafenib induced cardiotoxicity: Ex-vivo isolated heart and metabolites profiling studies in ratAhmed A Abdelgalil, Osama Y Mohamed, Syed Rizwan Ahamad, et al.
Pharmacological Reports : PR|February 21, 2019
Dasatinib significantly reduced in vivo exposure to cyclosporine in a rat model: The possible involvement of CYP3A inductionAhmed A Abdelgalil, Mohd Aftab Alam, Mohammad Raish, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Profiles of Drug Substances, Excipients, and Related Methodology|April 15, 2023
Crizotinib: A comprehensive profileAhmed A Abdelgalil, Hamad M Alkahtani
Profiles of Drug Substances, Excipients, and Related Methodology|April 15, 2023
Lapatinib: A comprehensive profileAhmed A Abdelgalil, Hamad M Alkahtani
Profiles of Drug Substances, Excipients, and Related Methodology|February 29, 2024
Regorafenib: A comprehensive drug profileAhmed A Abdelgalil, Hamad M Alkahtani
Profiles of Drug Substances, Excipients, and Related Methodology|April 29, 2019
SorafenibAhmed A Abdelgalil, Hamad M Alkahtani, Fahad I Al-Jenoobi
Profiles of Drug Substances, Excipients, and Related Methodology|March 14, 2020
ErlotinibAhmed A Abdelgalil, Hamad M Al-Kahtani, Fahad I Al-Jenoobi
Saudi Journal of Biological Sciences|April 30, 2020
Cigarette waste: Assessment of hazard to the environment and health in Riyadh cityWajhul Qamar, Ahmed A Abdelgalil, Suliman Aljarboa, et al.
European Journal of Pharmacology|June 8, 2020
The protective effect of losartan against sorafenib induced cardiotoxicity: Ex-vivo isolated heart and metabolites profiling studies in ratAhmed A Abdelgalil, Osama Y Mohamed, Syed Rizwan Ahamad, et al.
Pharmacological Reports : PR|February 21, 2019
Dasatinib significantly reduced in vivo exposure to cyclosporine in a rat model: The possible involvement of CYP3A inductionAhmed A Abdelgalil, Mohd Aftab Alam, Mohammad Raish, et al.
Pageof 1